The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
A Dopamine Hypothesis of Autism Spectrum Disorder
Abstract
Autism spectrum disorder (ASD) comprises a group of neurodevelopmental disorders characterized by social deficits and stereotyped behaviors. While several theories have emerged, the pathogenesis of ASD remains unknown. Although studies report dopamine signaling abnormalities in autistic patients, a coherent dopamine hypothesis which could link neurobiology to behavior in ASD is currently lacking. In this paper, we present such a hypothesis by proposing that autistic behavior arises from dysfunctions in the midbrain dopaminergic system. We hypothesize that a dysfunction of the mesocorticolimbic circuit leads to social deficits, while a dysfunction of the nigrostriatal circuit leads to stereotyped behaviors. Furthermore, we discuss 2 key predictions of our hypothesis, with emphasis on clinical and therapeutic aspects. First, we argue that dopaminergic dysfunctions in the same circuits should associate with autistic-like behavior in nonautistic subjects. Concerning this, we discuss the case of PANDAS (pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections) which displays behaviors similar to those of ASD, presumed to arise from dopaminergic dysfunctions. Second, we argue that providing dopamine modulators to autistic subjects should lead to a behavioral improvement. Regarding this, we present clinical studies of dopamine antagonists which seem to have improving effects on autistic behavior. Furthermore, we explore the means of testing our hypothesis by using neuroreceptor imaging, which could provide comprehensive evidence for dopamine signaling dysfunctions in autistic subjects. Lastly, we discuss the limitations of our hypothesis. Along these lines, we aim to provide a dopaminergic model of ASD which might lead to a better understanding of the ASD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The social motivation theory of autism
Chevallier, C., Kohls, G., Troiani, V., Brodkin, E. S., & Schultz, R. T. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2012.02.007 · Cited by 2,072
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574
Dopamine and the regulation of cognition and attention
Nieoullon, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00011-4 · Cited by 1,131
An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options
Masi, A., DeMayo, M. M., Glozier, N., & Guastella, A. J. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0100-y · Cited by 987
Advancing the understanding of autism disease mechanisms through genetics
de la Torre-Ubieta, L., Won, H., Stein, J. L., & Geschwind, D. H. (2016) · Nature Medicine · doi:10.1038/nm.4071 · Cited by 827
Amphetamine, past and present – a pharmacological and clinical perspective
Heal, D. J., Smith, S. L., Gosden, J., & Nutt, D. J. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113482532 · Cited by 617
McDougle, C. J., Scahill, L., Aman, M. G., McCracken, J. T., Tierney, E., Davies, M., Arnold, L. E., Posey, D. J., Martin, A., Ghuman, J. K., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1142 · Cited by 482
Scott‐Van Zeeland, A. A., Dapretto, M., Ghahremani, D. G., Poldrack, R. A., & Bookheimer, S. Y. (2010) · Autism Research · doi:10.1002/aur.122 · Cited by 458
The place of dopamine in the cortico-basal ganglia circuit
Haber, S. N. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.008 · Cited by 364
Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism
Horev, G., Ellegood, J., Lerch, J. P., Son, Y.-E. E., Muthuswamy, L., Vogel, H., Krieger, A. M., Buja, A., Henkelman, R. M., Wigler, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114042108 · Cited by 330
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Reward circuitry function in autism spectrum disorders
Dichter, G. S., Felder, J. N., Green, S. R., Rittenberg, A. M., Sasson, N. J., & Bodfish, J. W. (2012) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsq095 · Cited by 296
Animal models of restricted repetitive behavior in autism
LEWIS, M., TANIMURA, Y., LEE, L., & BODFISH, J. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.08.023 · Cited by 261
Is schizophrenia on the autism spectrum?
King, B. H., & Lord, C. (2011) · Brain Research · doi:10.1016/j.brainres.2010.11.031 · Cited by 255
Low medial prefrontal dopaminergic activity in autistic children
Ernst, M., Zametkin, A., Matochik, J., Pascualvaca, D., & Cohen, R. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63326-0 · Cited by 246
Dopamine hypothesis of schizophrenia: Making sense of it all
Toda, M., & Abi-Dargham, A. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0041-7 · Cited by 235
The pathophysiology of restricted repetitive behavior
Lewis, M., & Kim, S.-J. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9019-6 · Cited by 234
Reward circuitry function in autism during face anticipation and outcomes
Dichter, G. S., Richey, J. A., Rittenberg, A. M., Sabatino, A., & Bodfish, J. W. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1221-1 · Cited by 222
Yamauchi, T. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1342 · Cited by 208
Antibody-mediated neuronal cell signaling in behavior and movement disorders
Kirvan, C. A., Swedo, S. E., Snider, L. A., & Cunningham, M. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.06.017 · Cited by 201
The study of autism as a distributed disorder
Müller, R. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20141 · Cited by 194
Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics
Kazdoba, T. M., Leach, P. T., Yang, M., Silverman, J. L., Solomon, M., & Crawley, J. N. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_5003 · Cited by 170
Anagnostou, E., Soorya, L., Brian, J., Dupuis, A., Mankad, D., Smile, S., & Jacob, S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.049 · Cited by 155
Pharmacological therapies for autism spectrum disorder: a review.
(2015) · PubMed Central · Cited by 150
Post-infectious autoimmune disorders: Sydenham’s chorea, PANDAS and beyond
Williams, K. A., & Swedo, S. E. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.071 · Cited by 147
Activity-Dependent Modulation of Limbic Dopamine D3 Receptors by CaMKII
Liu, X., Mao, L., Zhang, G.-C., Papasian, C. J., Fibuch, E. E., Lan, H.-X., Zhou, H.-F., Xu, M., & Wang, J. Q. (2009) · Neuron · doi:10.1016/j.neuron.2008.12.015 · Cited by 130
Zürcher, N. R., Bhanot, A., McDougle, C. J., & Hooker, J. M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.02.002 · Cited by 108
Damiano, C. R., Aloi, J. M., Treadway, M. T., Bodfish, J. W., & Dichter, G. S. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-13 · Cited by 106
Gadow, K. D., Roohi, J., DeVincent, C. J., & Hatchwell, E. (2008) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2008.01952.x · Cited by 104
Selective blockade of spontaneous motor stereotypy via intrastriatal pharmacological manipulation
Presti, M. F., Mikes, H. M., & Lewis, M. H. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)01081-x · Cited by 97
A Common Variant in DRD3 Receptor Is Associated with Autism Spectrum Disorder
de Krom, M., Staal, W., Ophoff, R. A., Hendriks, J., Buitelaar, J. K., Franke, B., de Jonge, M. V., Bolton, P., Collier, D. A., Curran, S. R., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.035 · Cited by 85
Pediatric Acute-Onset Neuropsychiatric Syndrome
Murphy, T. K., Gerardi, D. M., & Leckman, J. F. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.06.001 · Cited by 79
Salavati, B., Rajji, T. K., Price, R., Sun, Y., Graff‐Guerrero, A., & Daskalakis, Z. J. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu132 · Cited by 77
Autism, DRD3 and repetitive and stereotyped behavior, an overview of the current knowledge
Staal, W. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.08.011 · Cited by 75
Regulation of molecular pathways in the Fragile X Syndrome: insights into Autism Spectrum Disorders
De Rubeis, S., & Bagni, C. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9087-2 · Cited by 73
Self injurious behavior in autism: clinical aspects and treatment with risperidone
Canitano, R. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0337-x · Cited by 67
Gadow, K. D., DeVincent, C. J., Olvet, D. M., Pisarevskaya, V., & Hatchwell, E. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07382.x · Cited by 64
Association between the oxytocin receptor (OXTR) gene and mesolimbic responses to rewards
Damiano, C. R., Aloi, J. M., Dunlap, K., Burrus, C. J., Mosner, M. G., Kozink, R. V., McLaurin, R. E., Mullette-Gillman, O. A., Carter, R., Huettel, S. A., et al. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-7 · Cited by 64
Scahill, L. D., Hallett, V., Aman, M. G., McDougle, C. J., Arnold, L. E., McCracken, J. T., Tierney, E., Deng, Y., Dziura, J. D., & Vitiello, B. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1689-3 · Cited by 49
DRD3 gene and striatum in autism spectrum disorder
Staal, W., Langen, M., van Dijk, S., Mensen, V. T., & Durston, S. (2015) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.148973 · Cited by 41
Glutamate-Mediated Signaling and Autism Spectrum Disorders: Emerging Treatment Targets
Yang, P., & Chang, C. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612819666140110120725 · Cited by 33
Administration of secretin for autism alters dopamine metabolism in the central nervous system
Toda, Y., Mori, K., Hashimoto, T., Miyazaki, M., Nozaki, S., Watanabe, Y., Kuroda, Y., & Kagami, S. (2005) · Brain and Development · doi:10.1016/j.braindev.2005.05.005 · Cited by 29
Ghaeli, P., Nikvarz, N., Alaghband‐Rad, J., Alimadadi, A., & Tehrani‐Doost, M. (2014) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.127254 · Cited by 19
Ferretti, J. J., Dl, S., & Va, F. (2016) · Cited by 10
Cited by
Teleanu, R. I., Niculescu, A.-G., Roza, E., Vladâcenco, O., Grumezescu, A. M., & Teleanu, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115954 · Cited by 596
Dan, Z., Mao, X., Liu, Q., Guo, M., Zhuang, Y., Liu, Z., Chen, K., Chen, J., Xu, R., Tang, J., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1747329 · Cited by 350
Marotta, R., Risoleo, M. C., Messina, G., Parisi, L., Carotenuto, M., Vetri, L., & Roccella, M. (2020) · Brain Sciences · doi:10.3390/brainsci10030163 · Cited by 279
Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder
Eissa, N., Al-Houqani, M., Sadeq, A., Ojha, S. K., Sasse, A., & Sadek, B. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00304 · Cited by 260
Schiavi, S., Carbone, E., Melancia, F., Buzzelli, V., Manduca, A., Campolongo, P., Pallottini, V., & Trezza, V. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1819107 · Cited by 34
Metadata
- Authors
- Pavăl, D.
- Venue
- Developmental Neuroscience
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 39
- Issue
- 5
- Pages
- 355-360
- ISSN
- 0378-5866 (ISSN-L)
- 1421-9859
- OpenAlex
- W2739669908
- Cited by
- 294
- References
- 44
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.